Bcl-2 and bcl-x expression in gangliogliomas

Human Pathology

Volumn 30, Issue 6, 1999, Pages 701-705

  Prayson, Richard A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; bcl 2; bcl x; Epilepsy; Ganglioglioma; MIB 1

Indexed keywords

PROTEIN BCL 2; PROTEIN BCL X;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; ASTROCYTOMA; CELL SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIA CELL; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; PROTEIN EXPRESSION; SEIZURE; TEMPORAL LOBE; TUMOR LOCALIZATION;

EID: 0032992186     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90097-7     Document Type: Article

References (47)

1. Morris HH, Estes ML, Gilmore R, et al: Chronic intractable epilepsy as the only symptom of primary brain tumor. J Neuropathol Exp Neurol 34:1038-1043, 1993
2. Wolf HK, Campos MG, Zentner J, et al: Surgical pathology of temporal lobe epilepsy: Experience with 216 cases. J Neuropathol Exp Neurol 52:499-506, 1993
3. Johannsson JH, Rekate HL, Roessmann V: Gangliogliomas: Pathological and clinical correlation. J Neurosurg 54:58-63, 1981
4. Khajavi K, Comair YG, Prayson RA, et al: Childhood ganglioglioma and medically intractable epilepsy. Pediatr Neurosurg 22:181-188, 1995
5. Garrido E, Becker LE, Hoffman HJ, et al: Gangliogliomas in children: A clinicopathological study. Child Brain 4:339-346, 1978
6. Cavanaugh JB: On certain small tumors encountered in the temporal lobe. Brain 81:389-405, 1958
7. Takahashi H, Wakabayashi K, Kawai K, et al: Neuroendocrine markers in central nervous system neuronal tumors (gangliocytoma and ganglioglioma). Acta Neuropathol 77:237-243, 1989
8. Diepholder H, Schwechheimer K, Mohadjer M, et al: A clinicopathologic and immunomorphologic study of 13 cases of ganglioglioma. Cancer 68:2192-2201, 1991
9. Lloyd R, Sisson JC, Shapiro B, et al: Immunohistochemical localization of epinephrine, norepinephrine, catecholamine synthesizing enzymes, and chromagranin in neuroendocrine cells and tumors. AmJ Pathol 125:45-54, 1986
10. Mendelsohn G, Eggleston JC, Olson JL, et al: Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors. Lab Invest 41:144-149, 1979
11. Mickle JP: Ganglioglioma in children: A review of 32 cases at the University of Florida. Pediatr Neurosurg 18:310-314, 1992
12. Takahashi H, Ikuta F, Tsuchida T, et al: Ultrastructural alterations of neuronal cells in a brainstem ganglioglioma. Acta Neuropathol 74:307-312, 1978
13. Prayson RA, Khajavi K, Comair YG: Cortical architectural abnormalities and MIB1 immunoreactivity in gangliogliomas: A study of 60 patients with intracranial tumors. J Neuropathol Exp Neurol 54:513-520, 1995
14. Wolf HK, Müller MB, Spänle M, et al: Ganglioglioma: A detailed histopathological and immunohistochemical analysis of 61 cases. Acta Neuropathol 88:166-173, 1994
15. Jay V, Becker LE, Otsubo H, et al: Pathology of temporal lobectomy for refractory seizures in children: Review of 20 cases including some unique malformative lesions. J Neurosurg 79:53-61, 1993
16. Prayson RA, Estes ML, Morris HH: Co-existence of neoplasia and cortical dysplasia in patients presenting with seizures. Epilepsia 34:609-615, 1993
17. Hirose T, Scheithauer B, Lopes M, et al: Ganglioglioma: An ultrastructural and immunochemical study. Mod Pathol 9:140A, 1996
18. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1-6, 1994
19. Hockenbery DM, Zutter M, Hickey W, et al: Bcl-2 protein is topographically restricted in times characterized by apoptotic cell death. Proc Natl Acad Sci U S A 88:6961-6965, 1991
20. Vaux DL, Cony S, Adams J: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B-cells. Nature 335:440-442, 1988
21. Korsemeyer S: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
22. L is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci 18:1009-1019, 1998
23. Boise LH, Gonzalez-Garcia M, Postema CE, et al: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608, 1993
24. Yachnis AT, Powell SZ, Olmsted JJ, et al: Distinct neurodevelopmental patterns of bcl-2 and bcl-x expression are altered in glioneuronal hamartias of the human temporal lobe. J Neuropathol Exp Neurol 56:186-198, 1997
25. Frankowski H, Missotlen M, Fernandez PA, et al: Function and expression of the bcl-x gene in developing and adult nervous system. Neuroreport 6:1917-1921, 1995
26. Kleihues P, Burger PC, Scheithauer BW: World Health Organization Histological Typing of Tumours of the Central Nervous System (ed 2). New York, NY, Springer-Verlag 1993, pp 23-24
27. Prayson RA, Estes ML: Cortical dysplasia: A histopathologic study of 52 cases of partial lobectomy in patients with epilepsy. HUM PATHOL 26:493-500, 1995
28. Tubbs RR, Sheibani K: Immunohistology of lymphoproliferative disorders. Semin Diagn Pathol 1:272-284, 1984
29. Goldblum JR, Shannon R, Kaljiam EP, et al: Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms. Mod Pathol 6:663-668, 1993
30. Daumas-Duport C, Scheithauer BW, Chodkiewicz J-P, et al: Dysembryoplastic neuroepithelial tumor: A surgically curable tumor of young patients with intractable partial seizures: Report of thirtynine cases. Neurosurgery 23:545-456, 1988
31. Daumas-Duport C: Dysembryoplastic neuroepithelial tumours. Brain Pathol 3:283-295, 1993
32. Prayson RA, Morris HH, Estes ML, et al: Dysembryoplastic neuroepithelial tumor: A clinicopathologic and immunohistochemical study of 11 tumors including MIB1 immunoreactivity. Clin Neuropathol 15:47-53, 1996
33. Raymond AA, Halpin SFS, Alsanjari N, et al: Dysembryoplastic neuroepithelial tumor: Features in 16 patients. Brain 117:461-475, 1994
34. Volk EE, Prayson RA: Hamartomas in the setting of chronic epilepsy: A clinicopathologic study of 13 cases. HUM PATHOL 28:227-232, 1997
35. Lach B, Duggal N, DaSilva VF, et al: Association of pleomorphic xanthoastrocytoma with cortical dysplasia and neuronal tumors: A report of three cases. Cancer 78:2551-2563, 1996
36. Perry A, Giannini C, Scheithauer BW, et al: Composite pleomorphic xanthoastrocytoma and ganglioglioma: Report of four cases and review of the literature. Am J Surg Pathol 21:763-771, 1997
37. Prayson RA: Composite ganglioglioma and dysembryoplastic neuroepithelial tumor. Arch Pathol Lab Med 123:247-250, 1999
38. Shimbo Y, Takahashi H, Hayano M, et al: Temporal lobe lesion demonstrating features of dysembryoplastic neuroepithelial tumor and ganglioglioma: A transitional form? Clin Neuropathol 16:65-68, 1997
39. Hirose T, Scheithauer BW: Mixed dysembryoplastic neuroepithelial tumor and ganglioglioma. Acta Neuropathol 95:649-654, 1998
40. Hara A, Hirose Y, Wang A, et al: Localization of Bax and Bcl-2 proteins, regulators of programmed cell death, in the human central nervous system. Virchows Arch 429:249-253, 1996
41. Castren E, Ohga Y, Brezaghi MP, et al: Bcl-2 messenger RNA is located in neurons of the developing and adult rat brain. Neuroscience 61:165-177, 1994
42. Ferrer I, Tortosa A, Condom E, et al: Increased expression of bcl-2 immunoreactivity in the developing cerebral cortex of the rat. Neurosci Lett 179:13-16, 1994
43. Farlie PG, Dringen R, Rees SM, et al: Bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc Natl Acad Sci U S A 92:4397-4401, 1995
44. Motoyama N, Wang F, Roth KA, et al: Massive cell death of immature hematopoietic cells and neurons in Bcl-x deficient mice. Science 267:1506-1510, 1995
45. Hara A, Hirose Y, Yoshimi N, et al: Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Neurol Res 19:623-628, 1997
46. Newcomb EW, Bhalla SK, Parrish CL, et al: Bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 94:369-375, 1997
47. Krajewski S, Krajewska M, Ehrmann J, et al: Immunohistochemical analysis of Bcl-2, Bcl-x, McI-1, and Bax in tumors of central and peripheral nervous system origin. Am J Pathol 150:805-814, 1997